Clinical, electrocardiographic and echocardiographic findings in significant cardiac amyloidosis detected only at necropsy: Comparison with cases diagnosed in life;Características clínicas, eletrocardiográficas e ecocardiográficas na amiloidose cardíaca significativa detectada apenas à necrópsia: Comparação com casos diagnosticados em vida

Arquivos Brasileiros de Cardiologia

Volumn 90, Issue 3, 2008, Pages

  Gutierrez, Paulo Sampaio ^a   Fernandes, Fábio ^a   Mady, Charles ^a   Higuchi, Maria De Lourdes ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Amyloidosis diagnosis; Echocardiography; Electrocardiography; Myocardium pathology

Indexed keywords

ARTICLE; AUTOPSY; CLINICAL ASSESSMENT; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FISHER EXACT TEST; HEART AMYLOIDOSIS; HEART DISEASE; HEART LEFT VENTRICLE; HUMAN; QUANTITATIVE ANALYSIS; RISK FACTOR; STUDENT T TEST; SYSTOLIC DYSFUNCTION;

EID: 42049104374     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2008000300009     Document Type: Article

References (15)

1. Ng B, Connors LH, Davidoff R, Skinner M, Falk RH. Senile systemic amyloidosis presenting with heart failure: a comparison with light chainassociated amyloidosis. Arch Intern Med. 2005; 165: 1425-9.
2. Kushwaha SS, Fallon JT, Fuster V. Restrictive cardiomyopathy. N Engl J Med. 1997; 336: 267-76.
3. Kristen AV, Meyer FJ, Perz JB, Schonland SO, Hundemer M, Hegenbart U, et al. Risk stratification in cardiac amyloidosis: novel approaches. Transplantation. 2005; 80 (Suppl): S151-5.
4. Kholova I, Niessen HW. Amyloid in the cardiovascular system: a review. J Clin Pathol. 2005; 58: 125-33.
5. Falk RH. Diagnosis and management of cardiac amyloidoses. Circulation. 2005; 112: 2047-60.
6. Neben-Wittich MA, Wittich CM, Mueller PS, Larson DR, Gertz MA, Edwards WD. Obstructive intramural coronary amyloidosis and myocardial ischemia are common in primary amyloidosis. Am J Med. 2005; 118: 1287. e1-1287.e7.
7. Ardehali H, Qasim A, Cappola T, Howard D, Hruban R, Hare JM, et al. Endomyocardial biopsy plays a role in diagnosing patients with unexplained cardiomyopathy. Am Heart J. 2004; 147: 919-23.
8. Sahn DJ, DeMaria AN, Kisslo J, Weyman A. The Committee on Mmode Standardization of the American Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978; 58: 1072-83.
9. Schiller NB, Shan PM, Crawford M, De Maria A, Devereux R, Feigebaum H, et al. American Society of Echocardiography Committee on Standards, subcommittee on quantification of two-dimensional echocardiograms. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. J Am Echocardiogr. 1989; 2: 358-67.
10. Teichholz LE, Cohen MV, Sonnenblick EH, Gorlin R. Study of left ventricular geometry and function by B-scan ultrasonography in patients with and without asynergy. N Engl J Med. 1974; 291:1220-6.
11. Cacoub P, Axler O, De Zuttere D, Hausfater P, Amoura Z, Walter S, et al. Amyloidosis and cardiac involvement. Ann Med Interne (Paris). 2000; 151 (8): 611-7.
12. Hassan W, Al-Sergani H, Mourad W, Tabbaa R. Amyloid heart disease: new frontiers and insights in pathophysiology, diagnosis, and management. Tex Heart Inst J. 2005; 32: 178-84.
13. Dubrey SW, Cha K, Simms RW, Skinner M, Falk RH. Electrocardiography and Doppler echocardiography in secondary (AA) amyloidosis). Am J Cardiol. 1996; 77: 313-5.
14. Murtagh B, Hammill SC, Gertz MA, Kyle RA, Tajik AJ, Grogan M. Electrocardiographic findings in primary systemic amyloidosis and biopsyproven cardiac involvement. Am J Cardiol. 2005; 95: 535-7.
15. Rahman JE, Helou EF, Gelzer-Bell R, Thompson RE, Kuo C, Rodriguez ER, et al. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol. 2004; 43: 410-5.